DanioLabs Ltd. Appoints Dr. Nigel Blackburn As Head Of Clinical Development

Published: Mar 08, 2006

By Suvarna Bhatt

San Francisco, March 8 (BioSpace) – DanioLabs, a Cambridge, United Kingdom based therapeutics company which focuses on neurology and ophthamology has appointed Dr Nigel Blackburn as Head of Clinical Development.

Nigel joins DanioLabs from Roche.

Contact Suvarna Bhatt at sbhatt@biospace.com.

Back to news